<DOC>
	<DOCNO>NCT00882388</DOCNO>
	<brief_summary>Background : - The prevalence arthritis need celecoxib prescription high patient coronary artery disease . - The main concern celecoxib would increase thrombogenicity inhibit synthesis prostacyclin endothelial cell . - It know whether administration celecoxib would deteriorate antiplatelet effect aspirin clopidogrel use stenting . Methods : - Healthy volunteer ( n=40 ) - Randomization five subgroup - aspirin , celecoxib , aspirin+celecoxib , aspirin+clopidogrel , aspirin+clopidogrel+celecoxib - Medication schedule : medication drug 6 day , blood sample day 0 day 7 - Celecoxib 200mg twice day , and/or aspirin 100mg daily , and/or clopidogrel 75 mg daily - Platelet function test : light transmittance aggregometry arachidonic acid metabolite assay among subgroup . Study hypothesis : The addition celecoxib deteriorate antiplatelet function aspirin clopidogrel .</brief_summary>
	<brief_title>The Effect Celecoxib Antiplatelet Effect Aspirin Clopidogrel Normal Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>healthy volunteer include men woman 20~30 year abnormality physical examination , 12lead ECG , routine laboratory test Subjects cardiovascular disease , hemostatic disorder , hypersensitivity NSAIDs clopidogrel Women positive pregnancy test smoker chronic drinker overweight exceed 20 % standard body weight</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>celecoxib</keyword>
	<keyword>platelet</keyword>
	<keyword>thrombosis</keyword>
	<keyword>Volunteers</keyword>
</DOC>